Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2015 Jan 1;8(1):906–913.

CREB1 gene polymorphisms combined with environmental risk factors increase susceptibility to major depressive disorder (MDD)

Peng Wang 1, Yanjie Yang 1, Xiuxian Yang 1, Xiaohui Qiu 1, Zhengxue Qiao 1, Lin Wang 1, Xiongzhao Zhu 2, Hong Sui 1, Jingsong Ma 1
PMCID: PMC4348828  PMID: 25755794

Abstract

Major depressive disorder (MDD) is one of the most severe psychiatric disorders. The objective of this study was to explore the effects of CREB1 gene polymorphisms on risk of developing MDD and the joint effects of gene-environment interactions. Genotyping was performed by Taqman allelic discrimination assay among 586 patients and 586 healthy controls. A significant impact on rs6740584 genotype distribution was found for childhood trauma (P = 0.015). We did not find an association of CREB1 polymorphisms with MDD susceptibility. However, we found a significantly increased risk associated with the interactions of CREB1 polymorphisms and drinking (OR = 11.67, 95% CI = 2.52-54.18; OR = 11.52, 95% CI = 2.55-51.95 for rs11904814; OR = 4.18, 95% CI = 1.87-9.38; OR = 5.02, 95% CI = 2.27-11.14 for rs6740584; OR = 7.58, 95% CI = 2.05-27.98; OR = 7.59, 95% CI = 2.12-27.14 for rs2553206; OR = 8.37, 95% CI = 3.02-23.23; OR = 7.84, 95% CI = 2.93-20.98 for rs2551941). We also noted that CREB polymorphisms combined with family harmony and childhood trauma conferred increased susceptibility for MDD. In conclusion, polymorphisms in the CREB gene may not be independently associated with MDD risk, but they are likely to confer increased susceptibility by interacting with environmental risk factors in the Chinese population.

Keywords: Polymorphism, CREB1, environmental risk factors, MDD, susceptibility

Introduction

CREB1 (cAMP response element-binding protein) is a transcription factor and plays an important role in neuronal signal transduction [1-3]. CREB1 protein, encoded by the CREB1 gene located on human chromosome 2q34, belongs to the leucine zipper family that serves as DNA-binding proteins [4]. The cAMP signal transduction pathway is induced by the activation of G-protein-coupled receptors and promoted through phosphorylation of the CREB protein [4,5]. Zubenko et al. reported a clear association of the loci in 2q33-35 chromosomal region with mood disorders in women [6] and identified that CREB1 predisposes to major depressive disorder (MDD) in a sex-specific manner [7]. An increasing body of literature confirmed that CREB1 might be involved in suicide [8-10], and antidepressant response in patients suffering from MDD [11-13]. Recently, Zubenko et al. identified a significant contribution of genetic variations in CREB1 to MDD in women [7]. Subsequent studies provided further support for the significant involvement of single nucleotide polymorphisms (SNP) at CREB1 locus in suicidal behaviors, anger expression and MDD, including rs467590, rs7569963 and G(-656)A [14-16].

MDD is a well-known mental disease resulting in cognitive dysfunction [17]. Many groups have demonstrated data on the substantial importance of SNPs in candidate genes in MDD pathogenesis and antidepressant response [18-20]. Results from family, twins and epidemiological studies indicated that about 30% to 40% of MDD incidences result from genetic factors and environmental carcinogens [21,22]. Caspi et al. showed that certain polymorphisms in the SLC6A4 gene regulate the effects of SLEs, including childhood maltreatment associated with MDD [23]. In recent years, a broad range of human genes and their interactions with exogenous variables have been identified to have an impact on the risk of developing MDD, such as FKBP5, CRHR1 and 5-HTTLPR [24-26]. However, few studies have previously focused on the joint effect of CREB1 gene polymorphisms and environmental factors. Herein, we studied the association of CREB1 SNPs with MDD and investigated the effects of common confounding factors in conjunction with these SNPs on the susceptibility to the disease.

Materials and methods

Participants

586 Chinese Han patients with MDD were recruited from Psychiatry Department of First Affiliated Hospital of Harbin Medical University. The patients were diagnosed by 2 experienced psychiatrists according to Diagnostic and Statistical manual of Disorders Fourth Edition (DMS-IV). All patients got more than 21 points in Hamilton’s Depression Scale Test and received no anti-depression treatment within 2 weeks before participation. We excluded the patients in case of the following conditions, brain organic mental disorders, other mental disease, and family history of genetic disease, mental retardation, dementia or physical disease. We also excluded the patients who provided insufficient information and accepted recent transfusion therapy. 586 unrelated controls were selected among the healthy individuals visiting the same hospital for physical examination and matched with cases in age (± 5 years), education and career. Their families had no substance dependent member, genetic diseases or interracial marriage in three generations. The baseline information is detailed in Table 1. The Research Ethics Committee of China approved the study and all participants signed the informed consent form.

Table 1.

Characteristics of the controls and MDD patients

Variables MDD/586 Controls/586 P
Age (years) 44.16 ± 0.56 42.93 ± 0.39 0.000
Gender 0.001
    Female 421 (71.84%) 370 (63.14%)
    Male 165 (28.16%) 216 (36.86%)
Marital status 0.720
    Single 85 (14.51%) 78 (13.31%)
    Stable 464 (79.18%) 475 (81.06%)
    Separated or widow 37 (6.31%) 33 (5.63%)
Smoking 0.019
    No 84 (14.33%) 114 (19.45%)
    Yes 502 (85.67%) 472 (80.55%)
Drinking < 0.001
    No 24 (4.10%) 111 (18.94%)
    Yes 562 (95.90%) 475 (81.06%)
Family harmony < 0.001
    No 189 (32.25%) 21 (3.58%)
    Yes 397 (67.74%) 565 (96.42%)
Working condition 0.330
    Stable 11 (1.88%) 16 (2.73%)
    Unstable 575 (98.12%) 570 (97.27%)
Childhood trauma 0.004
    No 528 (90.10%) 554 (94.54%)
    Yes 58 (9.90%) 32 (5.46%)

Measure of stressful life events

Life event scale (LES) proposed by Desen Yang and Yalin Zhang was used to evaluate stressful life events, such as serious illness, relationships, housing and social difficulties, relationship breakdowns, unemployment and financial crisis. This scale assessed four aspects of negative life events: when the life events occurred (absent = 1, 1 year earlier = 2, in a year = 3, chronicity = 4), how the life events were characterized (good = 1, bad = 2), to what extent the respondent was affected (absent = 1, mild = 2, moderate = 3, severe = 4, extreme = 5), and how long the influence lasted (less than 3 months = 1, 3-6 months = 2, 6-12 months = 3, more than 12 months = 4). A 75% percentile (a score of 4) in controls was taken as a cutoff value to group the events into the high or low level categories.

Measure of child maltreatment

Self-reported childhood maltreatment including abuse and neglect was recorded according to childhood trauma questionnaire (CTQ). It comprises 28 items graded on a five-point Likert scale, with higher scores corresponding to higher degree of traumatic experience. The scores were critical evidence to measure the degree of maltreatment: none = 0, low = 1, moderate = 2, severe and above = 3.

DNA isolation and genotyping

Genomic DNA was isolated from blood samples using a MagNA Pure DNA Isolator (Roche, Indianapolis, IN). Extracted DNA was used for genotyping. We selected 4 tag SNPs (rs11904814, rs6740584, rs2551941, rs2253206) from the whole-gene region of CREB1 using Haploview’s program. Analyses of SNPs were performed using Taqman allelic discrimination assay on a 7900 system (Applied Biosystem Inc) according to the manufacturer’s instructions. To ensure the allele discrimination accuracy, all samples were measured in triplicate, and the results yielded a 100% concordance rate.

Statistical analysis

Hardy-Weinberg equilibrium was evaluated for each polymorphism using χ2 test in both patients and controls. T-test was used to assess age difference between cases and controls. χ2-test was used to assess the between-group differences in gender, marital status, smoking, drinking, family harmony and working condition. Multi-factor variance analysis was performed to evaluate the association of demographic factors with genotype distribution. Logistic regression was used to test the SNP associations and the joint effects of gene-environment interactions. All analyses were carried out using SPSS 18.0. The values of P < 0.05 were considered statistically significant.

Results

Demographic and clinical data on study subjects

The characteristics of study subjects are listed in Table 1. The mean age was 44.16 in cases (male/female 28.2%/71.8%) and 42.93 in controls (male/female 36.9%/63.1%). A significant difference in gender distribution was detected between the two groups (P = 0.002). Most subjects were smokers (cases 85.7%, controls 80.6%) and alcohol drinkers (cases 95.9%, controls 81.1%). The cases were statistically different from controls both in alcohol consumption (P < 0.001) and tobacco smoking (P = 0.019). No significant difference was found in family harmony, marital status and working condition (P > 0.05).

Effect of CREB1 SNPs on MDD susceptibility

To evaluate the effects of CREB1 SNPs, we performed logistic regression. The results indicated no association between CREB1 polymoprhisms and MDD susceptibility (Table 2). We then explored the effects of demographic factors on genotype distribution (Table 3) and the data showed that childhood trauma was significantly associated with genotype distribution of rs6740584 in MDD patients (P = 0.015).

Table 2.

Association between CREB1 SNPs and MDD susceptibility

rs number Genotype MDD Control OR (95% CI) ORa (95% CI)
rs11904814 TT 83 86 1
TG 300 287 1.08 (0.77-1.53) 1.12 (0.76-1.65)
GG 203 213 0.99 (0.69-1.42) 1.04 (0.69-1.55)
rs6740584 TT 206 220 1
TC 299 282 1.13 (0.88-1.45) 1.15 (0.86-1.53)
CC 81 84 1.03 (0.72-1.48) 1.00 (0.66-1.49)
rs2253206 GG 86 89 1
GA 293 286 1.06 (0.76-1.49) 1.08 (0.74-1.59)
AA 207 211 1.02 (0.71-1.45) 1.04 (0.70-1.55)
rs2551941 AA 105 111 1
AT 293 281 0.87 (0.63-1.20) 1.12 (0.79-1.60)
TT 188 194 0.76 (0.54-1.07) 1.04 (0.71-1.52)
a

Adjusted by age, gender, marital status, smoking, drinking, family harmony, working condition and childhood trauma.

Table 3.

Association between demographic factors and genotype distribution in MDD patients

Factor/genotype rs11904814 P rs6740584 P rs2253206 P rs2551941 P




TT TG/GG TT TC/CC GG GA/AA AA AT/TT
Gender
    Female 62 359 0.533 149 272 0.847 62 359 0.956 76 345 0.893
    Male 21 144 57 108 24 141 29 136
Smoking
    No 11 73 0.762 23 61 0.107 13 71 0.823 13 71 0.529
    Yes 72 430 183 319 73 429 92 410
Drinking
    No 3 21 0.812 11 13 0.264 2 22 0.371 4 20 0.871
    Yes 80 482 195 367 84 478 101 461
Family harmony
    No 28 161 0.756 71 118 0.400 27 162 0.854 35 154 0.794
    Yes 55 342 135 262 59 338 70 327
Childhood trauma
    No 79 449 0.095 194 334 0.015* 82 446 0.078 99 429 0.113
    Yes 4 54 12 46 4 54 6 52
*

indicate a significant (P < 0.05) difference.

Combined effects of SNPs and drinking, family harmony and childhood trauma

Considering that the SNPs of CREB1 alone did not show any impact on MDD susceptibility, we analyzed the interactions between SNPs and drinking, family harmony and childhood trauma (Table 4). We found significantly increased risk of MDD associated with rs11904814 genotypes among drinkers (OR = 11.67, 95% CI = 2.52-54.18; OR = 11.52, 95% CI = 2.55-51.95). A similar trend was indicated for rs6740584, rs2253206 and rs2551941. These results demonstrated that drinking served as an important risk factor for MDD. We also found a significant role of family harmony in the risk of MDD. As shown in Table 5, lack of family harmony significantly promoted the development of MDD. In addition, we identified a 2.19-fold increased risk in relation to TC/CC genotypes of rs6740584 in conjunction with childhood trauma (OR = 2.19, 95% CI = 1.16-4.15, Table 6).

Table 4.

Interaction between drinking and CREB1 genetic polymorphisms

Variable Case Control OR (95% CI) ORa (95% CI)
rs11904814
    TT and no drinking 3 23 1 1
    TG or GG and no drinking 21 88 1.83 (0.50-6.67) 1.91 (0.41-8.97)
    TT and drinking 80 63 9.74 (2.80-33.90) 11.67 (2.52-54.18)
    TG or GG and drinking 482 412 8.97 (2.67-30.09) 11.52 (2.55-51.95)
rs6740584
    TT and no drinking 11 34 1 1
    TC or CC and no drinking 13 77 0.52 (0.21-1.28) 0.61 (0.24-1.59)
    TT and drinking 195 186 3.24 (1.60-6.58) 4.18 (1.87-9.38)
    TC or CC and drinking 367 289 3.93 (1.96-7.88) 5.02 (2.27-11.14)
rs2553206
    GG and no drinking 2 24 1 1
    GA or AA and no drinking 22 87 3.034 (0.666-13.825) 1.22 (0.32-4.59)
    GG and drinking 84 65 15.51 (3.54-68.01) 7.58 (2.05-27.98)
    GA or AA and drinking 478 410 13.99 (3.29-59.55) 7.59 (2.12-27.14)
rs2551941
    AA and no drinking 4 29 1 1
    AT or TT and no drinking 20 82 1.77 (0.56-5.61) 1.33 (0.45-3.89)
    AA and drinking 101 82 8.93 (3.02-26.43) 8.37 (3.02-23.23)
    AT or TT and drinking 461 393 8.50 (2.96-24.40) 7.84 (2.93-20.98)

Table 5.

Interaction between family harmony and CREB1 genetic polymorphisms

Variable Case Control OR (95% CI) ORa (95% CI)
rs11904814
    TT and harmony 55 85 1 1
    TT and no harmony 28 1 43.27 (5.72-327.28) 40.91 (5.40-309.81)
    TG or GG and harmony 342 480 1.10 (0.76-1.58) 1.07 (0.74-1.55)
    TG or GG and no harmony 161 20 12.41 (7.00-22.12) 12.71 (7.07-22.85)
rs6740584
    TT and harmony 135 213 1 1
    TT and no harmony 71 7 16.00 (7.15-35.82) 16.77 (7.47-37.66)
    TC or CC and harmony 262 352 1.17 (0.90-1.54) 1.24 (0.94-1.62)
    TC or CC and no harmony 118 14 13.30 (7.34-24.10) 13.78 (7.59-25.01)
rs2253206
    GG and harmony 59 86 1 1
    GG and no harmony 27 3 13.12 (3.80-45.24) 38.13 (5.04-288.68)
    GA or AA and harmony 338 479 1.03 (0.72-1.47) 1.03 (0.72-1.47)
    GA or AA and no harmony 162 18 13.12 (7.28-23.64) 11.69 (6.59-20.72)
rs2551941
    AA and harmony 70 105 1 1
    AA and no harmony 35 6 8.75 (3.50-21.90) 14.55 (4.96-42.67)
    AT or TT and harmony 327 460 1.07 (0.76-1.49) 1.13 (0.80-1.58)
    AT or TT and no harmony 154 15 15.40 (8.36-28.35) 13.86 (7.69-24.97)

Table 6.

Interaction between childhood trauma and CREB1 genetic polymorphisms

Variable Case Control OR (95% CI) ORa (95% CI)
rs11904814
    TT and no trauma 79 84 1 1
    TG or GG and no trauma 449 470 1.02 (0.72-1.42) 1.05 (0.75-1.48)
    TT and trauma 4 2 2.13 (0.38-11.94) 2.37 (0.41-13.61)
    TG or GG and trauma 54 30 1.91 (1.11-3.29) 1.43 (0.80-2.54)
rs6740584
    TT and no trauma 194 210 1 1
    TC or CC and no trauma 334 344 0.69 (0.82-1.35) 1.05 (0.82-1.35)
    TT and trauma 12 10 1.30 (0.55-3.08) 0.76 (0.34-1.70)
    TC or CC and trauma 46 22 2.26 (1.31-3.90) 2.19 (1.16-4.15)
rs2253206
    GG and no trauma 82 83 1 1
    GA or AA and no trauma 446 471 0.96 (0.69-1.34) 1.02 (0.73-1.42)
    GG and trauma 4 6 0.68 (0.18-2.48) 2.19 (0.39-12.50)
    GA or AA and trauma 54 26 2.10 (1.20-3.68) 1.37 (0.78-2.41)
rs2551941
    AA and no trauma 99 105 1 1
    AT or TT and no trauma 429 449 1.01 (0.75-1.37) 1.04 (0.76-1.41)
    AA and trauma 6 6 1.06 (0.33-3.40) 1.02 (0.32-3.28)
    AT or TT and trauma 52 26 2.12 (1.23-3.66) 1.48 (0.83-2.65)

Discussion

As genetic polymorphisms are usually impossible to work alone in predisposing human diseases, analysis of gene-environment interactions is frequently used to test the combined effects conferred by genetic polymorphsims and environment variables. It is reported that environmental factors such as emotional abuse, emotional and physical neglect are important components in the pathogenesis of depression [27,28]. Either high- or low-predisposing genes always function in combination with many exogenous substances [29]. Rice et al. found that candidate genes exert strong effects on depressive symptoms, stronger in males than in females [30]. Grabe et al. also reported that interaction of TAT-haolotype of CRHR1 and childhood physical neglect has a role in MDD pathogenesis [31]. Actually, various environmental factors are involved in the etiology of MDD, including gender, age and marital status as substantiated by Benitez et al. [32], neighborhood environment (OR = 2.2, 95% CI = 1.2-3.9) as suggested by Kessler et al. [33], and low self-esteem family depression, childhood abuse, traumatic experiences education state as indicated by Blanco et al. [34]. These data highlight the important role of exogenous substances in the development of MDD and identification of the risk factors may contribute to an increased understanding of the mechanisms that underlie this disease.

In the present study, we explored the effects of SNPs in CREB1 gene and gene-environment interactions on MDD susceptibility, and showed evidence of no association between MDD and CREB1 SNPs, a finding that contradicts Zubenko et al., indicating that CREB1 is a potential susceptibility locus for MDD [7], and Guo et al. reporting that rs6740584 of CREB1 has an effect on selective attention and retrieval [35]. As expected, we found a significantly increased risk when both polymorphisms and exogenous variables were considered. This joint effect is supported by Perlis et al., who found a strong, gender-specific association between variation at CREB1 locus and anger expression in MDD [15]. Although we cannot exclude the possibility that the lack of an association between CREB1 polymorphisms and MDD susceptibility is a false negative finding, it seems likely that the polymorphisms at CREB1 do not function alone in predisposing MDD, as suggested by Hettema et al. and Crisafulli et al. [36].

In addition, we evaluated the impact of demographic factors on the genotype distribution in MDD patients and only childhood trauma was identified as a regulatory factor of rs6740584 genotypes (P = 0.015). To obtain a more comprehensive understanding of MDD etiology, we assessed the association of MDD risk with gender, smoking, drinking, family harmony and childhood trauma (Table 1). A significant interaction was detected for drinking, family harmony and childhood trauma, which were found to increase genetic susceptibility to MDD by interplaying with various CREB1 SNPs. Appel et al. uncovered interactions between physical abuse and rs1360780 in the FKBP5 gene and confirmed its role in depression susceptibility [24]. Moreover, significant interactions between stressful life events and 5-HTTPR and BDNF genotypes were observed in patients with depression [26]. A recent study carried out by Wong et al. provided further evidence supporting the impact of exogenous factors (smoking, marriage status, age, alcohol abuse and gender) on susceptibility to major depression [37]. The previous studies along with the present study suggest that MDD is a heterogeneous disease and both genetic variations and a large repertoire of exogenous variables may have modulating effects on the susceptibility.

In conclusion, presence of CREB1 gene polymorphisms combined with exogenous factors including drinking, family harmony and childhood trauma may increase the risk of developing MDD. Further large-scale studies are warranted to identify the role of environment-genetic risk factors in the etiology of MDD, thus facilitating better understandings of MDD pathogenesis and subsequent preventive measures and treatment.

Acknowledgements

This research was supported by the National Natural Science Foundation of China (31271093, 81473054) to Prof. Yanjie Yang and the National Natural Science Foundation of China (81202213) to Xiuxian Yang.

Disclosure of conflict of interest

None.

References

  • 1.De Cesare D, Fimia GM, Sassone-Corsi P. CREM, a master-switch of the transcriptional cascade in male germ cells. J Endocrinol Invest. 2000;23:592–596. doi: 10.1007/BF03343781. [DOI] [PubMed] [Google Scholar]
  • 2.Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol. 2001;2:599–609. doi: 10.1038/35085068. [DOI] [PubMed] [Google Scholar]
  • 3.Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors in the nervous system. Neuron. 2002;35:605–623. doi: 10.1016/s0896-6273(02)00828-0. [DOI] [PubMed] [Google Scholar]
  • 4.Sands WA, Palmer TM. Regulating gene transcription in response to cyclic AMP elevation. Cell Signal. 2008;20:460–466. doi: 10.1016/j.cellsig.2007.10.005. [DOI] [PubMed] [Google Scholar]
  • 5.Mamdani F, Alda M, Grof P, Young LT, Rouleau G, Turecki G. Lithium response and genetic variation in the CREB family of genes. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:500–504. doi: 10.1002/ajmg.b.30617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zubenko GS, Maher B, Hughes HB 3rd, Zubenko WN, Stiffler JS, Kaplan BB, Marazita ML. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet B Neuropsychiatr Genet. 2003;123B:1–18. doi: 10.1002/ajmg.b.20073. [DOI] [PubMed] [Google Scholar]
  • 7.Zubenko GS, Hughes HB 3rd, Stiffler JS, Brechbiel A, Zubenko WN, Maher BS, Marazita ML. Sequence variations in CREB1 cosegregate with depressive disorders in women. Mol Psychiatry. 2003;8:611–618. doi: 10.1038/sj.mp.4001354. [DOI] [PubMed] [Google Scholar]
  • 8.Dwivedi Y, Rao JS, Rizavi HS, Kotowski J, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60:273–282. doi: 10.1001/archpsyc.60.3.273. [DOI] [PubMed] [Google Scholar]
  • 9.Odagaki Y, Garcia-Sevilla JA, Huguelet P, La Harpe R, Koyama T, Guimon J. Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims. Brain Res. 2001;898:224–231. doi: 10.1016/s0006-8993(01)02188-6. [DOI] [PubMed] [Google Scholar]
  • 10.Young LT, Bezchlibnyk YB, Chen B, Wang JF, MacQueen GM. Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment. Biol Psychiatry. 2004;55:570–577. doi: 10.1016/j.biopsych.2003.10.023. [DOI] [PubMed] [Google Scholar]
  • 11.Dowlatshahi D, MacQueen GM, Wang JF, Young LT. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet. 1998;352:1754–1755. doi: 10.1016/S0140-6736(05)79827-5. [DOI] [PubMed] [Google Scholar]
  • 12.Koch JM, Kell S, Hinze-Selch D, Aldenhoff JB. Changes in CREB-phosphorylation during recovery from major depression. J Psychiatr Res. 2002;36:369–375. doi: 10.1016/s0022-3956(02)00056-0. [DOI] [PubMed] [Google Scholar]
  • 13.Yamada S, Yamamoto M, Ozawa H, Riederer P, Saito T. Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J Neural Transm. 2003;110:671–680. doi: 10.1007/s00702-002-0810-8. [DOI] [PubMed] [Google Scholar]
  • 14.Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry. 2007;64:689–697. doi: 10.1001/archpsyc.64.6.689. [DOI] [PubMed] [Google Scholar]
  • 15.Perlis RH, Purcell S, Fagerness J, Cusin C, Yamaki L, Fava M, Smoller JW. Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder. Biol Psychiatry. 2007;62:536–540. doi: 10.1016/j.biopsych.2006.10.034. [DOI] [PubMed] [Google Scholar]
  • 16.Zubenko GS, Hughes HB 3rd. Effects of the G(-656)A variant on CREB1 promoter activity in a glial cell line: interactions with gonadal steroids and stress. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:579–585. doi: 10.1002/ajmg.b.30708. [DOI] [PubMed] [Google Scholar]
  • 17.Zubenko GS, Hughes HB 3rd. Effects of the G(-656)A variant on CREB1 promoter activity in a neuronal cell line: interactions with gonadal steroids and stress. Mol Psychiatry. 2009;14:390–397. doi: 10.1038/mp.2008.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hammar A, Ardal G. Cognitive functioning in major depression--a summary. Front Hum Neurosci. 2009;3:26. doi: 10.3389/neuro.09.026.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Angst J. The Prognosis of Antidepressive Treatments: Longitudinal and Genetic Studies. Anglo Ger Med Rev. 1965;2:733–751. [PubMed] [Google Scholar]
  • 20.Pare CM, Rees L, Sainsbury MJ. Differentiation of two genetically specific types of depression by the response to anti-depressants. Lancet. 1962;2:1340–1343. doi: 10.1016/s0140-6736(62)91019-x. [DOI] [PubMed] [Google Scholar]
  • 21.Serretti A, Franchini L, Gasperini M, Rampoldi R, Smeraldi E. Mode of inheritance in mood disorder families according to fluvoxamine response. Acta Psychiatr Scand. 1998;98:443–450. doi: 10.1111/j.1600-0447.1998.tb10117.x. [DOI] [PubMed] [Google Scholar]
  • 22.Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, Eaves LJ. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry. 1995;52:374–383. doi: 10.1001/archpsyc.1995.03950170048007. [DOI] [PubMed] [Google Scholar]
  • 23.Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Heath AC, Eaves LJ. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry. 1995;152:833–842. doi: 10.1176/ajp.152.6.833. [DOI] [PubMed] [Google Scholar]
  • 24.Appel K, Schwahn C, Mahler J, Schulz A, Spitzer C, Fenske K, Stender J, Barnow S, John U, Teumer A, Biffar R, Nauck M, Volzke H, Freyberger HJ, Grabe HJ. Moderation of adult depression by a polymorphism in the FKBP5 gene and childhood physical abuse in the general population. Neuropsychopharmacology. 2011;36:1982–1991. doi: 10.1038/npp.2011.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ressler KJ, Bradley B, Mercer KB, Deveau TC, Smith AK, Gillespie CF, Nemeroff CB, Cubells JF, Binder EB. Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:812–824. doi: 10.1002/ajmg.b.31052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, Yoon JS. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry. 2007;62:423–428. doi: 10.1016/j.biopsych.2006.11.020. [DOI] [PubMed] [Google Scholar]
  • 27.Kendler KS, Baker JH. Genetic influences on measures of the environment: a systematic review. Psychol Med. 2007;37:615–626. doi: 10.1017/S0033291706009524. [DOI] [PubMed] [Google Scholar]
  • 28.Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol. 2012;233:102–111. doi: 10.1016/j.expneurol.2011.10.032. [DOI] [PubMed] [Google Scholar]
  • 29.Meyer-Lindenberg A, Tost H. Neural mechanisms of social risk for psychiatric disorders. Nat Neurosci. 2012;15:663–668. doi: 10.1038/nn.3083. [DOI] [PubMed] [Google Scholar]
  • 30.Rice F, Harold G, Thapar A. The genetic aetiology of childhood depression: a review. J Child Psychol Psychiatry. 2002;43:65–79. doi: 10.1111/1469-7610.00004. [DOI] [PubMed] [Google Scholar]
  • 31.Grabe HJ, Schwahn C, Appel K, Mahler J, Schulz A, Spitzer C, Fenske K, Barnow S, Lucht M, Freyberger HJ, John U, Teumer A, Wallaschofski H, Nauck M, Volzke H. Childhood maltreatment, the corticotropin-releasing hormone receptor gene and adult depression in the general population. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:1483–1493. doi: 10.1002/ajmg.b.31131. [DOI] [PubMed] [Google Scholar]
  • 32.Hernandez-Benitez CT, Garcia-Rodriguez A, Leal-Ugarte E, Peralta-Leal V, Duran-Gonzalez J. [Enviromental factors related to depressive disorders] . Rev Med Inst Mex Seguro Soc. 2014;52:574–579. [PubMed] [Google Scholar]
  • 33.Kessler RC, Duncan GJ, Gennetian LA, Katz LF, Kling JR, Sampson NA, Sanbonmatsu L, Zaslavsky AM, Ludwig J. Associations of housing mobility interventions for children in high-poverty neighborhoods with subsequent mental disorders during adolescence. JAMA. 2014;311:937–948. doi: 10.1001/jama.2014.607. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • 34.Blanco C, Rubio J, Wall M, Wang S, Jiu CJ, Kendler KS. Risk factors for anxiety disorders: common and specific effects in a national sample. Depress Anxiety. 2014;31:756–764. doi: 10.1002/da.22247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Guo J, Liu Z, Dai H, Zhu Z, Wang H, Yang C, Xiao L, Huang Y, Wang G. Preliminary investigation of the influence of CREB1 gene polymorphisms on cognitive dysfunction in Chinese patients with major depression. Int J Neurosci. 2014;124:22–29. doi: 10.3109/00207454.2013.816956. [DOI] [PubMed] [Google Scholar]
  • 36.Hettema JM, An SS, van den Oord EJ, Neale MC, Kendler KS, Chen X. Association study of CREB1 with Major Depressive Disorder and related phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2009;150B:1128–1132. doi: 10.1002/ajmg.b.30935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wong ML, Dong C, Andreev V, Arcos-Burgos M, Licinio J. Prediction of susceptibility to major depression by a model of interactions of multiple functional genetic variants and environmental factors. Mol Psychiatry. 2012;17:624–633. doi: 10.1038/mp.2012.13. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES